Company / Cost of Revenue
Progyny Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$984.2M
FY2025
5-year range
$274.8M / $984.2M
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
#48 of 113
Health Care
What the data says
At $984M, Progyny's cost of revenue ranks #66 of 113 in the Health Care sector. Cost of Revenue has increased for 3 consecutive years, from $275M in FY2022 to $984M in FY2025.
Based on SEC 10-K filings.
$984M in FY2025 with a 5-year CAGR of +29.1%.
Increased from $850M to $984M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +53.0%
- 5-Year CAGR
- +29.1%
- 10-Year CAGR
- -
Sector benchmark
#66 of 113 in Health CareTop 58% of 113This company $984.2M Sector average $11.3B
▼
-91.3% below sector average
Key checks
Key Insights
- Progyny's cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +29.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 7.7% year-over-year.
- Ranks #48 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $984.2M | +7.7% |
| FY2024 | $913.9M | +7.5% |
| FY2023 | $849.8M | +209.2% |
| FY2022 | $274.8M | -29.3% |
| FY2021 | $388.5M | +41.4% |
| FY2020 | $274.8M | +49.2% |
| FY2019 | $184.2M | +114.2% |
| FY2018 | $86.0M | +108.7% |
| FY2017 | $41.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026